Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL468846 | 1.00 | CYP3A4 (0.36) | CYP3A4 | |
| Lactic Acid SCHEMBL15522845 | 0.89 | TP53 (0.37) | CYP3A4 | |
| SCHEMBL1966761 | 0.83 | — | — | |
| SCHEMBL8185651 | 0.81 | — | — | |
| SCHEMBL2544911 | 0.79 | OPRM1 (0.34) | — | |
| SCHEMBL1966290 | 0.77 | CYP2C19 (0.30) | — | |
| SCHEMBL1991499 | 0.76 | JAK3 (0.32) | — | |
| SCHEMBL15756820 | 0.76 | DPP4 (0.38) | — | |
| SCHEMBL10484687 | 0.76 | L3MBTL1 (0.33) | — | |
| SCHEMBL2682019 | 0.75 | CYP3A4 (0.40) | CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2124934-B1 | COSMETIC AND PHARMACEUTICAL APPLICATIONS OF N-ACETYLHYDROXYPROLINE | BEIERSDORF AG (DE) | 2015-04-08 | — | — | EP | claimed |
| US-20140128468-A1 | TOPICAL FILM-FORMING COMPOSITION, AND USE THEREOF FOR TREATING MYCOSES | LABORATOIRES URGO (FR) | 2014-05-08 | — | — | US | disclosed |
| CN-102046021-A | Film coated compressed chewing gum | FERTIN PHARMA AS | 2011-05-04 | — | — | CN | disclosed |
| EP-1159952-B1 | N-Acetylhydroxyproline for improving the moisture retention function of the epidermis | KYOWA HAKKO KOGYO KK (JP) | 2009-01-14 | — | — | EP | disclosed |
| EP-1660493-B1 | PEPTIDYL HETEROCYCLIC KETONE DERIVATIVES AND PREPARATION PROCESSES | JANSSEN PHARMACEUTICA NV (BE) | 2008-10-08 | — | — | EP | disclosed |
| US-7291739-B2 | 3, 4-disubstituted pyridine compounds; | IMPERIAL INNOVATIONS LIMITED (GB) | 2007-11-06 | — | — | US | disclosed |
| EP-1660493-A1 | PEPTIDYL HETEROCYCLIC KETONE DERIVATIVES AND PREPARATION PROCESSES | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-05-31 | — | — | EP | disclosed |
| WO-2005023804-A1 | PEPTIDYL HETEROCYCLIC KETONE DERIVATIVES AND PREPARATION PROCESSES | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-03-17 | — | — | WO | disclosed |
| EP-0826773-B1 | Process for producing trans-4-hydroxy-l-proline | KYOWA HAKKO KOGYO KK (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-6743922-B2 | 3-SUBSTITUENT HIGHLY RESISTANT TO ROTATION-4-TERTIARY AMINO-PYRIDINE | UNIVERSITY OF SHEFFIELD (GB) | 2004-06-01 | — | — | US | disclosed |
| EP-0826773-A2 | Process for producing trans-4-hydroxy-l-proline | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1998-03-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140128468-A1 | TOPICAL FILM-FORMING COMPOSITION, AND USE THEREOF FOR TREATING MYCOSES | CUTA, NACA, DPM1 | CYP3A4 3627/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.